LIM domain-binding protein 2 Antibody [PCRP-LDB2-1A10]

In Stock
Catalog Number Formulation Size Price
9079-MSM1-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$259.00
9079-MSM1-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$559.00
9079-MSM1-P1ABX
Purified Ab WITHOUT BSA or Azide at 1.0mg/ml
100ug
$559.00
Flat Rate Domestic: $95 | Orders outside the US - Contact Us for Order Information | Ships next business day

Applications & Dilutions

Applications Tested Dillution Protocol
Flow Cytometry (Flow)
1-2ug/million cells
Immunofluorescence (IF)
1-3ug/ml

Summary

Transcription cofactor. Binds to the LIM domain of a wide variety of LIM domain-containing transcription factors.

Product Properties & Targets

Antibody Type
Host
Mouse
Species Reactivity
Isotype / Light Chain
IgG /
Cellular Localization
Nucleus
Gene Name
Immunogen
Recombinant human LDB2 protein
Alternate Names
LIM domain-binding protein 2, CLIM1|LDB-2|LDB1

Database Links

Entrez Gene ID
SwissProt

Additional Information

Clone
PCRP-LDB2-1A10
Chromosome Location
4p15.32
Mol. Weight of Antigen
42.79kDa
Purification
Protein A

Functions

  • Transcription cofactor. Binds to the LIM domain of a wide variety of LIM domain-containing transcription factors.

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab purified from Bioreactor Concentrate by Protein A. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK